See the DrugPatentWatch profile for Beovu
What does “Beovu 6 semaines” mean?
“Beovu 6 semaines” usually refers to a dosing interval for Beovu (brolucizumab) of about once every 6 weeks during the treatment schedule, often used as a maintenance approach after the initial loading phase.
How is Beovu typically scheduled before spacing to 6 weeks?
Beovu is given by intravitreal injection (into the eye). Treatment starts with an initial series of doses, and then the injection interval may be adjusted based on how the condition responds, with the goal of maintaining vision and controlling retinal fluid.
Does everyone stay on a 6-week interval?
No. The interval can differ from person to person. Clinicians generally individualize dosing based on signs of disease activity (for example, whether fluid is still present on exam or imaging) and patient response over time. That means some patients may need more frequent injections than 6 weeks, while others may be able to extend beyond it.
Why do patients search “6 weeks” with Beovu?
People often look up “6 weeks” because:
- they were told their injections will be scheduled every 6 weeks after starting
- they’re comparing injection frequency between anti-VEGF eye treatments
- they want to understand what maintenance dosing looks like after the first few doses
What to check with your prescriber
If you’re using or considering Beovu, the most important details are the exact regimen your ophthalmologist prescribed (including how many initial doses you received and what the next visit interval is).
If you tell me what you’re treating (e.g., wet AMD, diabetic macular edema, retinal vein occlusion) and whether you’re in the starting phase or maintenance, I can narrow down what “6 semaines” likely refers to in that context.